ReviewPulmonary therapy2022
Hepatic Hydrothorax: A Narrative Review.
Review in Pulmonary therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 18 citations in OpenAlex.
- [Thoracoscopic diaphragmatic plication technique in a patient with refractory hepatic hydrothorax].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Pulmonary Complications in Cirrhosis: Current Concepts and Clinical Perspectives.Biomedicines · 2026Review
- A Rare Presentation of Right-Sided Pleural Effusion in Decompensated Chronic Liver Disease Secondary to Hepatitis C Infection: A Case Report.Clinical case reports · 2026Article
- Symptomatic pleural effusion in adult liver transplant candidates: prevalence, disease severity and post-transplant mortality.BMC pulmonary medicine · 2025Article
- Hepatic hydrothorax as a manifestation of decompensated cirrhosis: An update on current management and future directions.World journal of hepatology · 2025Review
- A Practical Approach to Pleural Infection.Pulmonary therapy · 2025Article
- The Impact of Hepatic Hydrothorax on the Outcome of Liver Cirrhosis: A Comparative Study.Journal of clinical medicine · 2025Article
- Application of methylene blue injection staining in the diagnosis of hepatic pleural effusion in patients with cirrhosis-a case report and literature review.AME case reports · 2025Article
- A Rare, Atypical Presentation of Decompensated Cirrhosis: Isolated Transudative Hepatic Chylothorax Without Ascites.Case reports in hepatology · 2025Article
- Innovative Management of a Difficult Case of Hepatic Hydrothorax.ACG case reports journal · 2024Article
- Article
- Computer-Aided Diagnosis of Complications After Liver Transplantation Based on Transfer Learning.Interdisciplinary sciences, computational life sciences · 2024Article
- Hepatic hydrothorax.Journal of thoracic disease · 2024Review
- Diagnosis and Management of Hepatic Hydrothorax.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024Review
- Left hepatic hydrothorax without ascites.BMJ case reports · 2024Article
- Risk factors for hepatic hydrothorax in patients with cirrhosis: a clinical retrospective study.Frontiers in medicine · 2023Article
- Hepatic Hydrothorax: A Comprehensive Approach to Diagnosis and Management.GE Portuguese journal of gastroenterologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic hydrothorax (HH) represents a distinct clinical entity within the broader classification of pleural effusion that is associated with significant morbidity and mortality. The median survival of patients with cirrhosis who develop HH is 8-12 months. The diagnosis is typically made in the context of advanced liver disease and ascites, in the absence of underlying cardio-pulmonary pathology. A multi-disciplinary approach to management, involving respiratory physicians, hepatologists, and palliative care specialists is crucial to ensuring optimal patient-centered care. However, the majority of accepted therapeutic options are based on expert opinion rather than large, adequately powered randomized controlled trials. In this narrative review, we discuss the epidemiology, pathophysiology, clinical characteristics, and management of HH, highlighting the use of salt restriction and diuretic therapy, porto-systemic shunts, and liver transplantation. We include specific sections focusing on the role of pleural interventions and palliative care, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.